Prosecution Insights
Last updated: May 29, 2026

Examiner: MUMMERT, STEPHANIE KANE

Tech Center 1600 • Art Units: 1637 1681

This examiner grants 61% of resolved cases

Performance Statistics

60.6%
Allow Rate
+0.6% vs TC avg
792
Total Applications
+22.0%
Interview Lift
1401
Avg Prosecution Days
Based on 759 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
14.3%
§102 Novelty
75.6%
§103 Obviousness
3.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17048953 Compositions and Methods for Diagnosis and Treatment of Endometriosis Non-Final OA The Board of Regents of the University of Texas System
18233606 METHODS FOR SPATIAL ANALYSIS USING RNA-TEMPLATED LIGATION Non-Final OA 10x Genomics, Inc.
17677525 ANALYTICAL STANDARDS AND METHODS OF USING SAME Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
17411671 METHOD FOR DETECTING A PLURALITY OF SHORT-CHAIN NUCLEIC ACID IN SAMPLE, COMBINATORIAL ANALYSIS KIT, ANALYSIS KIT SUPPLY MANAGEMENT METHOD Non-Final OA KABUSHIKI KAISHA TOSHIBA
17646179 GENDER-SPECIFIC MARKERS FOR DIAGNOSING PROGNOSIS AND DETERMINING TREATMENT STRATEGY FOR RENAL CANCER PATIENTS Non-Final OA THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
17574032 UNIVERSAL REPORTER-BASED GENOTYPING METHODS AND MATERIALS Non-Final OA LIFE TECHNOLOGIES CORPORATION
18105233 MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION Final Rejection Wuhan University
17526743 SINGLE-STEP DNA PREPARATION FOR POLYMERASE CHAIN REACTION USING MAGNETIC CHITOSAN MICROPARTICLES Non-Final OA Canon U.S.A., Inc.
18751083 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
18751175 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Final Rejection Natera, Inc.
18747138 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
18678417 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
18126344 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
18111804 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
17868141 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
17196659 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Non-Final OA Natera, Inc.
16734814 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Final Rejection Natera, Inc.
18045687 NUCLEIC ACID SEQUENCING METHODS AND SYSTEMS Non-Final OA Pacific Biosciences of California, Inc.
17845481 DETECTION OF COLORECTAL CANCER Non-Final OA Universal Diagnostics, S.A.
17498290 ISOLATION OF TARGET NUCLEIC ACIDS Non-Final OA Harbinger Health, Inc.
18119750 METHOD OF IDENTIFYING A PLURALITY OF MICROORGANISMS AND BIOMARKERS FOR ANTIBIOTIC RESISTANCE FROM A SAMPLE USING NUCLEICACID AMPLIFICATION TECHNOLOGY (NAT) Non-Final OA MANI M
17696027 Oscillating Amplification Reaction For Nucleic Acids Final Rejection Mesa Biotech, Inc.
17504903 SAMPLE PREPARATION FOR DIFFICULT SAMPLE TYPES Final Rejection BioFire Diagnostics, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month